Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 2
2021 6
2022 4
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean takahiro matsumura[Author] (8 results)?
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer.
Honda T, Seto K, Endo S, Takemoto A, Tanimoto K, Kobayashi M, Kitano M, Sakakibara R, Mitsumura T, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K. Honda T, et al. Among authors: mitsumura t. Cancer Med. 2023 Oct;12(19):19406-19413. doi: 10.1002/cam4.6535. Epub 2023 Sep 15. Cancer Med. 2023. PMID: 37712717 Free PMC article.
Predictors associated with clinical improvement of SARS-CoV-2 pneumonia.
Mitsumura T, Okamoto T, Shirai T, Iijima Y, Sakakibara R, Honda T, Ishizuka M, Aiboshi J, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Mitsumura T, et al. J Infect Chemother. 2021 Jun;27(6):857-863. doi: 10.1016/j.jiac.2021.02.012. Epub 2021 Feb 16. J Infect Chemother. 2021. PMID: 33676842 Free PMC article.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.
Ikeda M, Okugawa S, Kashiwabara K, Moritoyo T, Kanno Y, Jubishi D, Hashimoto H, Okamoto K, Tsushima K, Uchida Y, Mitsumura T, Igari H, Tsutsumi T, Araoka H, Yatera K, Yamamoto Y, Nakamura Y, Otani A, Yamashita M, Wakimoto Y, Shinohara T, Adachi-Katayama M, Oyabu T, Kanematsu A, Harada S, Takeshita Y, Nakano Y, Miyazaki Y, Sakao S, Saito M, Ogura S, Yamasaki K, Kawasuji H, Hataji O, Inoue JI, Seto Y, Moriya K. Ikeda M, et al. Among authors: mitsumura t. Int J Infect Dis. 2023 Mar;128:355-363. doi: 10.1016/j.ijid.2022.12.039. Epub 2023 Jan 4. Int J Infect Dis. 2023. PMID: 36610659 Free PMC article. Clinical Trial.
High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.
Yin Y, Sakakibara R, Honda T, Kirimura S, Daroonpan P, Kobayashi M, Ando K, Ujiie H, Kato T, Kaga K, Mitsumura T, Nakano R, Sakashita H, Matsuge S, Ishibashi H, Akashi T, Hida Y, Morohoshi T, Azuma M, Okubo K, Miyazaki Y. Yin Y, et al. Among authors: mitsumura t. Thorac Cancer. 2023 Jul;14(20):1991-2000. doi: 10.1111/1759-7714.14981. Epub 2023 May 30. Thorac Cancer. 2023. PMID: 37253418 Free PMC article.
Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images.
Aoki H, Miyazaki Y, Anzai T, Yokoyama K, Tsuchiya J, Shirai T, Shibata S, Sakakibara R, Mitsumura T, Honda T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Yamamoto M, Takahashi K, Tateishi U, Yamaguchi T. Aoki H, et al. Among authors: mitsumura t. Eur Radiol. 2024 Jan;34(1):374-383. doi: 10.1007/s00330-023-09937-x. Epub 2023 Aug 3. Eur Radiol. 2024. PMID: 37535157
Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.
Aoyagi Y, Kano Y, Tohyama K, Matsudera S, Kumaki Y, Takahashi K, Mitsumura T, Harada Y, Sato A, Nakamura H, Sueoka E, Aragane N, Kimura K, Onishi I, Takemoto A, Akahoshi K, Ono H, Ishikawa T, Tokunaga M, Nakagawa T, Oshima N, Nakamura R, Takagi M, Asakage T, Uetake H, Tanabe M, Miyake S, Kinugasa Y, Ikeda S. Aoyagi Y, et al. Among authors: mitsumura t. PLoS One. 2022 Mar 31;17(3):e0266112. doi: 10.1371/journal.pone.0266112. eCollection 2022. PLoS One. 2022. PMID: 35358259 Free PMC article.
Ablation of miR-146b in mice causes hematopoietic malignancy.
Mitsumura T, Ito Y, Chiba T, Matsushima T, Kurimoto R, Tanaka Y, Kato T, Uchida K, Ito T, Yamamoto K, Eishi Y, Kitagawa M, Miyazaki Y, Inase N, Asahara H. Mitsumura T, et al. Blood Adv. 2018 Dec 11;2(23):3483-3491. doi: 10.1182/bloodadvances.2018017954. Blood Adv. 2018. PMID: 30530754 Free PMC article.
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
Oba S, Hosoya T, Kaneshige R, Kawata D, Yamaguchi T, Mitsumura T, Shimada S, Shibata S, Tateishi T, Koike R, Tohda S, Hirakawa A, Yoko N, Otomo Y, Nojima J, Miyazaki Y, Yasuda S. Oba S, et al. Among authors: mitsumura t. Front Immunol. 2023 Oct 16;14:1227547. doi: 10.3389/fimmu.2023.1227547. eCollection 2023. Front Immunol. 2023. PMID: 37908357 Free PMC article.
MuLBSTA score is a useful tool for predicting COVID-19 disease behavior.
Iijima Y, Okamoto T, Shirai T, Mitsumura T, Sakakibara R, Honda T, Ishizuka M, Tateishi T, Tamaoka M, Aiboshi J, Otomo Y, Anzai T, Takahashi K, Miyazaki Y. Iijima Y, et al. Among authors: mitsumura t. J Infect Chemother. 2021 Feb;27(2):284-290. doi: 10.1016/j.jiac.2020.10.013. Epub 2020 Oct 13. J Infect Chemother. 2021. PMID: 33129694 Free PMC article.
23 results